COLPALNSEColgate Palmolive (India) Limited· Personal CareLowNeutral
Announced Fri, 22 May · 20:19 IST

Colgate Palmolive (India) Limited has informed the Exchange about newsletter

Mgmt Guided Margin ImprovementInvestor Communications View source PDF

COLPAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹2158.90
prior close
₹2185.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-1.0-1.5-4.5-3.2-3.1-4.4-7.7-7.6-7.1-2.8-7.8-1.1
Up moveDown movePending
AI summary

Colgate Palmolive India reported Q4 FY26 net sales of Rs 1,582.8 crore, up 9% year-on-year, showing a strong rebound in growth. Net profit for Q4 stood at Rs 353.3 crore, with management highlighting underlying profit margin at 9% excluding one-offs and exceptional items. For the full year FY26, net sales were Rs 5,983.6 crore and net profit was Rs 1,325.3 crore, both slightly lower than FY25 levels. The company announced a second interim dividend of Rs 24 per share, bringing total dividend for FY26 to Rs 48 per share. Key highlights include a partnership with Mumbai Indians for oral health awareness and recognition as a leading ESG entity by Dun & Bradstreet.

Likely market impact

The 9% Q4 sales growth signals recovery in demand, though full-year performance shows modest decline. The total dividend of Rs 48 per share provides shareholder returns despite profit contraction. The underlying margin disclosure (9% excluding one-offs) indicates management transparency on core profitability.